Skip to content

Effect of intravenous diazepam in reduction shoulder joint dislocation

Comparison of combination of intravenous diazepam and fentanyl with combination of intravenous midazolam and fentanyl in reduction of shoulder joint dislocation in emergency department

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170313033051N1
Enrollment
80
Registered
2019-03-30
Start date
2019-02-20
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder dislocation. Subluxation and dislocation of shoulder joint

Interventions

Intervention 1: Intervention group: Administration of intravenous Diazepam and intravenous Fentanyl. After obtaining the consent of the patient to participate in the study and to place him randomly in

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The need for analgesia for joint reduction No severe underlying diseases Age 18 to 65 years The desire to participate in the study

Exclusion criteria

Exclusion criteria: Lack of desire to participate in the study Sensitivity to drug used in study Pregnancy Hemodynamic instability Presence of fracture associated with dislocation

Design outcomes

Primary

MeasureTime frame
Patient satisfaction according to pain scale. Timepoint: Before reduction, during the reduction and after the reduction. Method of measurement: Using Visual Analogue Scale.;Uncomplicated joint reduction. Timepoint: During the reduction and after the reduction with intervals 15 minutes for 2 hours. Method of measurement: Examination of vital signs and level of consciousness during and after the procedure.;Physician Satisfaction. Timepoint: After reduction. Method of measurement: sing Likert scale.

Secondary

MeasureTime frame
No need for post-reduction care. Timepoint: During and after the reduction for 2 hours and at intervals of 15 minutes. Method of measurement: Using Glasgow Coma Scale and vital sign monitoring with sphygmomanometer and pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Afzalimoghaddam

Tehran University of Medical Sciences

afzalimoghadam@tums.ac.ir+98 21 6690 4848

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026